Jürgen Debus mainly focuses on Radiation therapy, Nuclear medicine, Surgery, Radiation treatment planning and Radiology. Jürgen Debus is studying Radiosurgery, which is a component of Radiation therapy. His Nuclear medicine research integrates issues from Chordoma, Chondrosarcoma, Skull and Carbon Ion Radiotherapy.
His work on Tumor progression expands to the thematically related Surgery. His Radiation treatment planning research incorporates elements of Astrocytoma, Conformal radiotherapy and Head and neck. His studies in Radiology integrate themes in fields like Trigeminal neuralgia and Retrospective cohort study.
His primary areas of study are Radiation therapy, Nuclear medicine, Radiology, Internal medicine and Surgery. His work carried out in the field of Radiation therapy brings together such families of science as Retrospective cohort study, Magnetic resonance imaging and Chemotherapy. His Nuclear medicine study combines topics from a wide range of disciplines, such as Relative biological effectiveness, Irradiation, Carbon Ion Radiotherapy and Planning target volume.
Jürgen Debus combines Radiology and In patient in his studies. His research in Internal medicine intersects with topics in Gastroenterology and Oncology. The study of Surgery is intertwined with the study of Toxicity in a number of ways.
His primary areas of investigation include Radiation therapy, Radiology, Internal medicine, Nuclear medicine and Oncology. His Radiation therapy study incorporates themes from Magnetic resonance imaging, Breast cancer and Randomized controlled trial. The study incorporates disciplines such as Adverse effect and Prostate cancer in addition to Radiology.
His research is interdisciplinary, bridging the disciplines of Gastroenterology and Internal medicine. The Nuclear medicine study combines topics in areas such as Planning target volume and Proton therapy, Proton. His biological study deals with issues like Cancer, which deal with fields such as Cancer research.
Jürgen Debus mostly deals with Radiation therapy, Nuclear medicine, Radiology, Internal medicine and Cancer research. His Radiation therapy research is multidisciplinary, incorporating elements of Ion beam, Monte Carlo method and Meningioma. The concepts of his Nuclear medicine study are interwoven with issues in Magnetic resonance imaging, Mr imaging, Chondrosarcoma and Relative biological effectiveness.
His Radiology study combines topics in areas such as Clinical research, Skull and Prostate cancer. His biological study spans a wide range of topics, including Gastroenterology and Oncology. Jürgen Debus has researched Cancer research in several fields, including Fibroblast activation protein, alpha, Stem cell, Apoptosis and Biodistribution.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh;Eleni Avtzi;Frederik L. Giesel;Tim Holland-Letz.
European Journal of Nuclear Medicine and Molecular Imaging (2015)
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
Andreas Engert;Annette Plütschow;Hans Theodor Eich;Andreas Lohri.
The New England Journal of Medicine (2010)
DNA methylation-based classification of central nervous system tumours
David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt.
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh;Christian M. Zechmann;Anna Malcher;Matthias Eder.
European Journal of Nuclear Medicine and Molecular Imaging (2014)
Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial.
Klaus K. Herfarth;Jürgen Debus;Frank Lohr;Malte L. Bahner.
Journal of Clinical Oncology (2001)
Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial
Hans Theodor Eich;Volker Diehl;Helen Görgen;Thomas Pabst.
Journal of Clinical Oncology (2010)
Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases.
A Pirzkall;J Debus;F Lohr;M Fuss.
Journal of Clinical Oncology (1998)
Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience.
Tadashi Kamada;Hirohiko Tsujii;Eleanor A Blakely;Jürgen Debus.
Lancet Oncology (2015)
RESULTS OF CARBON ION RADIOTHERAPY IN 152 PATIENTS
Daniela Schulz-Ertner;Anna Nikoghosyan;Christoph Thilmann;Thomas Haberer.
International Journal of Radiation Oncology Biology Physics (2004)
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.
Ali Afshar-Oromieh;Ali Afshar-Oromieh;Tim Holland-Letz;Frederik L. Giesel;Clemens Kratochwil.
European Journal of Nuclear Medicine and Molecular Imaging (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: